The global cattle & porcine/swine reproductive diseases market growth is primed to transition from $758.2 million in 2024 to $975.8 million by 2029, showcasing a strong CAGR of 5.2%. Increasing investments, funding, and grants from various governments and organizations to improve animal health, along with a growing number of veterinarians in developing nations, are enhancing the treatment of diseases.
The enterprise monitoring market is projected to reach USD 80.26 by 2029 billion, at a CAGR of 18.0% during the forecast period. The report profiles key players such as Microsoft(US), IBM (US), Cisco (US), Dynatrace (US), Datadog (US), New Relic (US), Elastic N.V. (US), (US), BMC Software (US), Zoho Corporation (India), Logic Monitor (US), SolarWinds (US), Paessler (Germany), Trianz (US), ScienceLogic (US), Grafana Labs (US), VirtualMetric (Netherlands), Coralogix (US), Nagios (US), Pandora FMS (Spain), Sumo Logic (US), Atatus (India), Zabbix (Latvia), Checkmk (Germany), Logz.io (US), Icinga (Germany), Hubstaff (US), and EfficientLab (US).
The doors & windows market is expected to grow from USD 199.47 billion in 2024 to USD 244.21 billion by 2029, at a CAGR of 4.1% during the forecast period. The Doors & Windows market comprises key manufacturers such as ASSA ABLOY (Sweden), LIXIL Corporation (Japan), Cornerstone Building Brands, Inc. (US), JELD-WEN, Inc. (US), YKK AP Inc. (Japan), Masonite (US), PELLA CORPORATION (US), Schüco International KG (Germany), ANDERSEN CORPORATION (US), and PGT INNOVATIONS (US) among others are the major players in the doors & windows market.
The global pain management devices market growth is primed to transition from $3,768.6 million in 2024 to $5,835.8 million by 2029, showcasing a strong CAGR of 9.1%. The surging cases of chronic pain conditions globally, the launch and approval of new advanced products, and favorable developments in government policies to promote low-cost devices will stimulate market growth.
The high purity gas market is expected to grow from USD 34.62 billion in 2024 to USD 48.57 billion in 2029, at a CAGR of 7.0% during the forecast period. Prominent companies include Linde Plc (Ireland), Air Liquide (France), Air Products and Chemicals, Inc. (US), Iwatani Corporation (Japan), Messer SE & Co. KGaA (Germany), Matheson Tri-Gas Inc. (US), Daigas Group (Japan), Nippon Sanso Holdings Corporation (Mitsubishi Chemical Group Corporation, Japan), SOL India Private Limited (India), Ingas (Ukraine), Gruppo SIAD (Italy), Resonac Holdings Corporation (Japan), LLC “Akela-N”(Russia), Alchemie Gases & Chemicals Pvt. Ltd. (India), Bhuruka Gases Limited (India), Chemix Specialty Gases and Equipment (India), Ultra Pure Gases (I) Pvt. Ltd. (India), Coregas (Australia), Seralgaz (Turkey), PurityPlus (US), Woikoski Oy (Finland), Specialty Gases Company Limited (Saudi Arabia), Amar Gases (India), Qingdao Baigong Industrial and Trading Co., Ltd. (China)and among others.
The global bioconjugation market growth is primed to transition from USD 5.27 billion in 2024 to USD 10.86 billion by 2029, showcasing a strong CAGR of 15.6%. The bioconjugation market is experiencing significant growth with the advancement of bioconjugation technologies, which increase precision, efficacy, and safety in therapeutic & diagnostic applications. Next-generation bioconjugates, especially those fabricated by site-specific conjugation techniques, have been more effective than inherent limitations encountered by traditional routes of bioconjugation.
The digital cockpit market size, in terms of volume, is 45 million units in 2024 and is expected to reach around 67 million units by 2030. The market is expected to exhibit a CAGR of 7.0% during the forecast period. The top OEMs in the market are General Motors (USA), Stellantis N. V. (Netherlands), Honda Motors (Japan), Volkswagen (Germany), Ford (USA), Xpeng (China), Zeekr (China), Rivian (US), Tata Motors (India) and so on. These companies adopted new product launches, acquisitions, partnerships, collaborations, and other key strategies to gain traction in the digital cockpit market.
The air-cooled heat exchanger market is expected to grow from USD 3.96 Billion in 2024 to USD 5.69 Billion by 2029, at a CAGR of 7.5% during the forecast period. Mergers, new product launches and expansions are the major growth strategies adopted by the key players in the market. The key global players in the air-cooled heat exchangers market include ALFA LAVAL (Sweden), Kelvion Holding GmbH (Germany), Kawasaki Heavy Industries, Ltd. (Japan), Xylem (US), Exchanger Industries Limited (Canada), SPX Cooling Tech, LLC (US), SNT Energy Co., Ltd. (South Korea), Thermax Limited (India), Baker Hughes Company (US), Chart Industries (US), Armstrong International Inc. (US), and KNM Group Berhad (Malaysia).
The global body contouring treatments market growth is primed to transition from $1.46 billion in 2024 to $2.58 billion by 2029, showcasing a strong CAGR of 10.0%. A major driver is the growing adoption of minimally invasive and non-invasive body contouring procedures.
The n-butanol market is expected to grow from USD 5.63 billion in 2024 to USD 7.50 billion by 2029, at a CAGR of 5.9% during the forecast period. Acquisitions, new product launches, expansion and partnerships are the major growth strategies adopted by the key players in the market. The key global players in the n-butanol market include BASF (Germany), Dow (US), SABIC (Saudi Arabia), Mitsubishi Chemical Group Corporation (Japan), Eastman Chemical Company (US), Sasol Limited (South Africa), OQ Chemicals GmbH (Germany), PetroChina Company Limited (China), KH Neochem Co., Ltd. (Japan), and PETRONAS Chemicals Group Berhad (Malaysia).
The ammonia market is expected to grow from USD 79.47 billion in 2024 to USD 91.95 billion by 2029, at a CAGR of 3.0% during the forecast period. The report profiles key players such as CF Industries Holdings, Inc. (US), Yara International ASA (Norway), OCI Global (Netherlands), BASF SE (Germany), and Nutrien (Canada).
The global mRNA synthesis & manufacturing market growth is primed to transition from USD 738.3 million in 2024 to USD 624.4 billion by 2029, showcasing a strong CAGR of 3.4%. The primary drivers behind the expansion of this industry are the Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mRNA technology, advancements in mRNA synthesis technology, increased outsourcing for mRNA synthesis and modification, and collaborations among industry players.
The Chinese automotive industry sales (PV+CV) were 30.1 million units in 2023, estimated to reach 31.4 million units in 2024 and are expected to reach around 38.2 million units by 2030 at a CAGR of 3.5%. The top Chinese OEMs in the market are BYD, Company Ltd., Geely Group, Chery Automobile, Changan Group, SAIC, Great Wall Motor, Nio, XPeng, Li Auto, Leapmotor, Xiaomi, etc. The other companies that support the Chinese automobile industry with technology development are Baidu, ecar, Neusoft, Alibaba, Tencent, CATL, Gotion, CALB, SVOLT and others. These Chinese OEMs have adopted new product launches, acquisitions, partnerships, collaborations, and other key strategies to gain traction in the global automotive market.
The global digital denture market growth is primed to transition from $1.42 billion in 2024 to $2.16 billion in 2029, showcasing a strong CAGR of 8.7%. The major drivers for the growth in the digital dentures market are improvements in digital technology
The polymer foam market is expected to grow from USD 102.61 billion in 2024 to USD 142.02 billion by 2030, at a CAGR of 5.6% during the forecast period. Some of the leading players in this market include ARMACELL (Luxembourg), Sheela Foam Limited (India), Kingspan Insulation, LLC (Ireland), Owens Corning (US), and Zotefoams plc (UK).